Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001062822-25-000023
Filing Date
2025-04-22
Accepted
2025-04-22 07:07:36
Documents
18
Period of Report
2025-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A lxrx-20250421.htm   iXBRL DEF 14A 1243903
6 lxrx-20250421_g1.jpg GRAPHIC 74820
7 lxrx-20250421_g2.gif GRAPHIC 11974
  Complete submission text file 0001062822-25-000023.txt   2067964

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20250421.xsd EX-101.SCH 2475
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lxrx-20250421_def.xml EX-101.DEF 2666
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20250421_lab.xml EX-101.LAB 2991
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20250421_pre.xml EX-101.PRE 1737
20 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20250421_htm.xml XML 105304
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30111 | Film No.: 25854946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)